Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.3B | 2.0B | 2.1B | 2.2B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 53M | -9M | 68M | 51M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 28M | -3M | 24M | 26M |
| Other income expense | 0 | 0 | 0 | 0 |
| Pretax income | 377M | 219M | 431M | 444M |
| Tax provision | 92M | 38M | 96M | 100M |
| Net income | 285M | 181M | 336M | 317M |
| Basic EPS | 0.1 | — | — | — |
| Diluted EPS | 0.1 | — | — | — |
| Basic average shares | 2.6B | — | — | — |
| Diluted average shares | 2.6B | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 377M | 219M | 432M | 417M |
| Minority interests | 0 | -1M | -16M | -7M |
| Preferred stock dividends | — | — | — | — |